TY - JOUR
T1 - The Factors Associated with the Selection of Early Excision Surgery for Congenital Biliary Dilatation with a Prenatal Diagnosis
AU - Shirai, Takeshi
AU - Matsuura, Toshiharu
AU - Tamaki, Akihiko
AU - Kajihara, Keisuke
AU - Uchida, Yasuyuki
AU - Kawano, Yuki
AU - Toriigahara, Yukihiro
AU - Obata, Satoshi
AU - Kawakubo, Naonori
AU - Yoshimaru, Koichiro
AU - Yanagi, Yusuke
AU - Nagata, Kouji
AU - Kouhashi, Kenichi
AU - Oda, Yoshinao
AU - Tajiri, Tatsuro
N1 - Publisher Copyright:
© 2023 Elsevier Inc.
PY - 2023/7
Y1 - 2023/7
N2 - Purpose: The aim of this study was to clarify the appropriate management after birth for congenital biliary dilatation (CBD, choledochal cyst) patients with a prenatal diagnosis. Method: Thirteen patients with a prenatal diagnosis of CBD who underwent liver biopsy during excision surgery were divided into two groups and retrospectively analyzed: group A, with liver fibrosis above F1 and group B, without liver fibrosis. Results: Excision surgery was performed earlier in group A (F1–F2), at a median of 106 days old (p = 0.04). There were significant differences between the two groups in the presence symptoms and sludge, the cyst size, and the level of serum bilirubin and gamma glutamyl transpeptidase (GGT) before excision surgery (p < 0.05). Especially, in group A, prolonged serum GGT elevation and larger cysts were consistently observed from birth. The cut-off values of predictions for the presence of liver fibrosis in serum GGT and cyst size were 319 U/l and 45 mm. No significant differences were observed in the postoperative liver function or complications during the follow-up period. Conclusion: In patients with prenatally diagnosed CBD, the postnatal serial changes of serum GGT values and cyst size, in addition to symptoms, could help to prevent progressive liver fibrosis. Level of Evidence: Ⅲ. Type of Study: Treatment Study.
AB - Purpose: The aim of this study was to clarify the appropriate management after birth for congenital biliary dilatation (CBD, choledochal cyst) patients with a prenatal diagnosis. Method: Thirteen patients with a prenatal diagnosis of CBD who underwent liver biopsy during excision surgery were divided into two groups and retrospectively analyzed: group A, with liver fibrosis above F1 and group B, without liver fibrosis. Results: Excision surgery was performed earlier in group A (F1–F2), at a median of 106 days old (p = 0.04). There were significant differences between the two groups in the presence symptoms and sludge, the cyst size, and the level of serum bilirubin and gamma glutamyl transpeptidase (GGT) before excision surgery (p < 0.05). Especially, in group A, prolonged serum GGT elevation and larger cysts were consistently observed from birth. The cut-off values of predictions for the presence of liver fibrosis in serum GGT and cyst size were 319 U/l and 45 mm. No significant differences were observed in the postoperative liver function or complications during the follow-up period. Conclusion: In patients with prenatally diagnosed CBD, the postnatal serial changes of serum GGT values and cyst size, in addition to symptoms, could help to prevent progressive liver fibrosis. Level of Evidence: Ⅲ. Type of Study: Treatment Study.
UR - http://www.scopus.com/inward/record.url?scp=85150376241&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85150376241&partnerID=8YFLogxK
U2 - 10.1016/j.jpedsurg.2023.01.050
DO - 10.1016/j.jpedsurg.2023.01.050
M3 - Article
C2 - 36914460
AN - SCOPUS:85150376241
SN - 0022-3468
VL - 58
SP - 1246
EP - 1251
JO - Journal of Pediatric Surgery
JF - Journal of Pediatric Surgery
IS - 7
ER -